Long-Term Drug Shortage – Zerbaxa® (ceftolozane/tazobactam)
April 23, 2021 - The drug shortage of Merck’s Zerbaxa (ceftolozane/tazobactam) injection is ongoing. Zerbaxa has been unavailable for at least 90 days due to requirements related to complying with good manufacturing practices.
Download PDF
